miR-16, for example, affects the proliferation and angiogenesis of pituitary cancer via VEGFR-2/p38/ nuclear factor ’kappa-light-chain-enhancer’ of activated B-cells (NF-κB) signaling [47]. The gene discussed is KDR; the disease is pituitary cancer.